These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 18925509)

  • 21. Lysophosphatidic acid-induced mitogenesis is regulated by lipid phosphate phosphatases and is Edg-receptor independent.
    Hooks SB; Santos WL; Im DS; Heise CE; Macdonald TL; Lynch KR
    J Biol Chem; 2001 Feb; 276(7):4611-21. PubMed ID: 11042183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lysophosphatidic acid as a regulator of endothelial/leukocyte interaction.
    Rizza C; Leitinger N; Yue J; Fischer DJ; Wang DA; Shih PT; Lee H; Tigyi G; Berliner JA
    Lab Invest; 1999 Oct; 79(10):1227-35. PubMed ID: 10532586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family.
    Noguchi K; Ishii S; Shimizu T
    J Biol Chem; 2003 Jul; 278(28):25600-6. PubMed ID: 12724320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of lysophospholipid receptors in human platelets: the relation of two agonists, lysophosphatidic acid and sphingosine 1-phosphate.
    Motohashi K; Shibata S; Ozaki Y; Yatomi Y; Igarashi Y
    FEBS Lett; 2000 Feb; 468(2-3):189-93. PubMed ID: 10692584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dioleoyl phosphatidic acid increases intracellular Ca2+ through endogenous LPA receptors in C6 glioma and L2071 fibroblasts.
    Chang YJ; Kim YL; Lee YK; Sacket SJ; Kim K; Kim HL; Han M; Bae YS; Okajima F; Im DS
    Prostaglandins Other Lipid Mediat; 2007 Jun; 83(4):268-76. PubMed ID: 17499746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alkyl lysophosphatidic acid and fluoromethylene phosphonate analogs as metabolically-stabilized agonists for LPA receptors.
    Xu Y; Tanaka M; Arai H; Aoki J; Prestwich GD
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5323-8. PubMed ID: 15454220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The bioactive phospholipid lysophosphatidic acid is released from activated platelets.
    Eichholtz T; Jalink K; Fahrenfort I; Moolenaar WH
    Biochem J; 1993 May; 291 ( Pt 3)(Pt 3):677-80. PubMed ID: 8489494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-activity relationships of fluorinated lysophosphatidic acid analogues.
    Xu Y; Aoki J; Shimizu K; Umezu-Goto M; Hama K; Takanezawa Y; Yu S; Mills GB; Arai H; Qian L; Prestwich GD
    J Med Chem; 2005 May; 48(9):3319-27. PubMed ID: 15857137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adhesion of human platelets to albumin is synergistically increased by lysophosphatidic acid and adrenaline in a donor-dependent fashion.
    Eriksson AC; Whiss PA; Nilsson UK
    Blood Coagul Fibrinolysis; 2006 Jul; 17(5):359-68. PubMed ID: 16788312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lysophosphatidic acids. II. Interaction of the effects of adenosine diphosphate and lysophosphatidic acids in dog, rabbit, and human platelets.
    Gerrard JM; Kindom SE; Peterson DA; White JG
    Am J Pathol; 1979 Dec; 97(3):531-47. PubMed ID: 315721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strategy for the identification of GPR23/LPA4 receptor agonists and inverse agonists.
    Wong SH; Mallari R; Graham M; Atangan L; Lu SC; Zhao X; Gu W; Lee PH
    Assay Drug Dev Technol; 2010 Aug; 8(4):459-70. PubMed ID: 20482379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors.
    Ohta H; Sato K; Murata N; Damirin A; Malchinkhuu E; Kon J; Kimura T; Tobo M; Yamazaki Y; Watanabe T; Yagi M; Sato M; Suzuki R; Murooka H; Sakai T; Nishitoba T; Im DS; Nochi H; Tamoto K; Tomura H; Okajima F
    Mol Pharmacol; 2003 Oct; 64(4):994-1005. PubMed ID: 14500756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dioleoyl phosphatidic acid induces morphological changes through an endogenous LPA receptor in C6 glioma cells.
    Chang YJ; Kim YL; Jo JY; Kyeok K; Kim HL; Im DS
    Arch Pharm Res; 2008 May; 31(5):628-33. PubMed ID: 18481020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lysophosphatidic Acid signals through specific lysophosphatidic Acid receptor subtypes to control key regenerative responses of human gingival and periodontal ligament fibroblasts.
    George J; Headen KV; Ogunleye AO; Perry GA; Wilwerding TM; Parrish LC; McVaney TP; Mattson JS; Cerutis DR
    J Periodontol; 2009 Aug; 80(8):1338-47. PubMed ID: 19656035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lysophosphatidic acid-induced Ca2+ mobilization in human A431 cells: structure-activity analysis.
    Jalink K; Hengeveld T; Mulder S; Postma FR; Simon MF; Chap H; van der Marel GA; van Boom JH; van Blitterswijk WJ; Moolenaar WH
    Biochem J; 1995 Apr; 307 ( Pt 2)(Pt 2):609-16. PubMed ID: 7733903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lysophosphatidic acid stimulation of platelets rapidly induces Ca2+-dependent dephosphorylation of cofilin that is independent of dense granule secretion and aggregation.
    Pandey D; Goyal P; Siess W
    Blood Cells Mol Dis; 2007; 38(3):269-79. PubMed ID: 17321765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lysophosphatidic acid-independent platelet activation by low-density lipoprotein.
    Korporaal SJ; Relou IA; van Rijn HJ; Akkerman JW
    FEBS Lett; 2001 Apr; 494(1-2):121-4. PubMed ID: 11297747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitogenic action of lysophosphatidic acid and phosphatidic acid on fibroblasts. Dependence on acyl-chain length and inhibition by suramin.
    van Corven EJ; van Rijswijk A; Jalink K; van der Bend RL; van Blitterswijk WJ; Moolenaar WH
    Biochem J; 1992 Jan; 281 ( Pt 1)(Pt 1):163-9. PubMed ID: 1731751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic and pharmacodynamic characterization of an oral lysophosphatidic acid type 1 receptor-selective antagonist.
    Swaney JS; Chapman C; Correa LD; Stebbins KJ; Broadhead AR; Bain G; Santini AM; Darlington J; King CD; Baccei CS; Lee C; Parr TA; Roppe JR; Seiders TJ; Ziff J; Prasit P; Hutchinson JH; Evans JF; Lorrain DS
    J Pharmacol Exp Ther; 2011 Mar; 336(3):693-700. PubMed ID: 21159750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of residues responsible for ligand recognition and regioisomeric selectivity of lysophosphatidic acid receptors expressed in mammalian cells.
    Fujiwara Y; Sardar V; Tokumura A; Baker D; Murakami-Murofushi K; Parrill A; Tigyi G
    J Biol Chem; 2005 Oct; 280(41):35038-50. PubMed ID: 16115890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.